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Foreword 
 
The European Commission's Joint Research Centre (JRC) provides scientific support to 
European Union policies, including nanotechnology. The increasing use of manufactured 
nanomaterials (NMs) in a number of commercial applications and consumer products 
raises questions regarding potential unintended risks to humans and the environment. 
For a number of years the JRC has been active in the development, optimisation and 
harmonisation of test methods suitable for hazard assessment of NMs. International 
harmonisation of these test methodologies is ensured, among others, through JRC’s 
participation in the Organisation for Economic Co-operation and Development (OECD) 
Working Party of Manufactured Nanoparticles (WPMN).  
The OECD WPMN’s programme on the safety of manufactured nanomaterials addresses 
all the different components needed for thorough risk assessments for human health and 
the environment, including the availability of reliable methods for the purpose of NMs 
safety assessment. At an expert meeting held in Paris in October 2014 it was concluded 
that the scientific information available to date is not sufficient to fully support a 
harmonised version of the in vitro micronucleus test protocol because the existing or 
published data were not generated in a harmonised way and do not provide answers to 
some key questions. In particular, questions remain regarding the uptake on NMs, dosing 
regimens, necessary length of exposure to NMs or scheme of treatment to cytochalasin 
B. The OECD WPMN approved a JRC led project aiming at the adaptation of the in vitro 
micronucleus test (Test Guideline 487) for the assessment of manufactured NMs that was 
subsequently included by the OECD-WNT in the work plan of the Test Guidelines 
Programme (Project 4.95). Therefore, work aiming to develop a Guidance Document 
(GD) addressing the necessary adaptations of current genotoxicity TGs for nanomaterials 
testing was initiated under the coordination of JRC. This report summarises the results of 
the first stage of the project. 
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Abstract 
This report presents the results from a study organised under the coordination of JRC as 
part of a project aiming at the adaptation of the in vitro micronucleus test (Test Guideline 
487) for the assessment of manufactured NMs. The aim of the first step of the project 
was to evaluate the physicochemical characterisation of selected representative 
nanomaterials (5 nm gold, 30 nm gold, 22 nm silica, 30 nm citrate and 30 nm PVP 
stabilised silver nanoparticles) in pure water and in different complete culture media. 
The results of the study show that using a combination of different characterisation 
techniques is important to providing reliable information about the agglomeration1 
behaviour of the tested nanoparticles in complete cell culture media (CCM). Most of the 
materials exhibited mild agglomeration in serum containing CCM. Only the PVP 
functionalised silver nanoparticles showed a size distribution change in all of the culture 
media that is so small that it could be attributed to solely protein adsorption without 
notable agglomeration. Silica nanoparticles were found to be the most sensitive to 
interaction with serum containing CCM, showing massive concentration and time 
dependent agglomeration strongly affected by the CCM composition. Extensive 
agglomeration might lead also to the accelerated sedimentation of the particles changing 
drastically the true, effective dose that the cells will receive under in vitro conditions1 . 
Thus, it has to be investigated in more detail and taken in account when designing in 
vitro experiments in the next phase of the project. 
                                           
1 See section on abbreviations nomenclature 
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1 Introduction 
A “Nanomaterial” according to the European Commission recommended definition is a   
natural, incidental or manufactured material containing particles, in an unbound state or 
as an aggregate or as an agglomerate and where, for 50 % or more of the particles in 
the number size distribution, one or more external dimensions is in the size range 1 nm - 
100 nm. 3 Nanomaterials are used in a variety of industrial sectors and in numerous 
consumer products, such as paint, catalysts, sports items, surface treatment products, 
textiles, cosmetic products, food additives and packaging, vehicle tyres, electronic items 
and analytical chemical equipment. Some applications are new, while others, such as 
paint and catalysts, have been around for many years.  
Nanomaterials (NMs) are often well-known chemical substances that can exhibit new 
physical and chemical characteristics when produced in a nanoform. Gold for example, in 
bulk form, is typically an inert, shiny yellow metal but in nanoform can become very 
catalytically active or show optical properties which change depending on particle size 
and shape. Other examples of new characteristics that materials may possess at the 
nanoscale are anomalous electrical conductivity and superparamagnetism. The 
complexity of nanomaterial behaviour stems from the fact that the same chemical 
substance can be used in a variety of different nanoforms that may display a wide range 
of properties including size, shape, surface functionalisation, surface charge, that affect 
their way of interacting with biological systems such as biological fluids (protein-surface 
interactions) and living cells (cellular uptake, mechanisms of toxic response). This 
renders their safety assessment challenging.4-7 
Nanotechnology is a rapidly developing field and it is expected that an increasing number 
of new NMs will be developed and put on the market in the near future. To enable a quick 
and reliable safety assessment of NMs used in consumer products, there is an urgent 
need to provide robust, standardized in vitro test methods for toxicity screening. 
However, due to the special properties of these materials (including their high surface 
area) they may show unexpected interferences in classical in vitro toxicity assays.8-14 
The EC JRC is contributing to the development and optimisation of in vitro methods 
suitable for the hazard assessment of NMs.6, 11, 15 Well-established in vitro methods for 
the testing of chemicals are adapted for NMs by investigating possible interferences of 
the NMs with the assays. The JRC study presented here is focused on the relationship 
between the physicochemical properties of the NMs under in vitro conditions and the 
observed biological response. Special attention is paid to the development of methods for 
NM dosimetry to quantify the effective cellular dose. This work is performed in 
collaboration with the OECD Working Party on Nanomaterials (WPMN).16-18 
The first phase of the study includes the identification of the necessary changes in the 
protocol of the micronucleus in vitro assay (TG487) when used to test NMs, taking into 
account the physicochemical characterisation of NMs, kinetics of intracellular uptake and 
NMs dosimetry in vitro. This report presents the results and conclusions from the 
physicochemical characterisation of selected nanoparticles for Adaptation of In vitro 
Mammalian Micronucleus Test Guideline (TG 487) for Testing of Manufactured 
Nanomaterials. 
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2 Synthesis, sourcing and physicochemical characterisation 
of stock suspensions 
2.1 Materials 
The nanoparticles (NPs) used in this study were obtained either by in-house synthesis 
(AuNPs of 5 and 30 nm diameter and SiO2NPs of 22 nm diameter) or from the supplier 
nanoComposix (30 nm Cit-AgNPs and PVP-AgNPs). Table 2.1 summarises the 
representative nanoparticles (NPs) selected for the study. 
Table 2.1  List of nanomaterials tested in the study 
NPs name 
Nominal 
size (nm) 
Batch 
number 
Supplier 
AuNPs 5 IO176A JRC in-house synthesis 
AuNPs 30 IO194B JRC in-house synthesis 
Cit-AgNPs 30 DMW0208 NanoComposix 
PVP-AgNPs 30 MXR0002 NanoComposix 
SiO2NPs 22 IO122B JRC in-house synthesis 
 
In case of the in-house synthesised materials the following sections will detail the 
synthesis method and principal physicochemical characteristics of the materials as 
determined shortly after synthesis. The Cit-AgNPs and PVP-AgNPs which were purchased 
from the commercial supplier NanoComposix were initially in suspension and the 
synthesis routes will not be detailed but physicochemical properties will be reported. 
The cell culture media (CCM) tested in the study in the presence of serum together with 
their commercial source information are summarised in Table 2.2. All complete culture 
media contained Penicillin – Streptomycin at 100 x dilution (at concentrations of 
100 U/mL and 100 µg/mL). 
 
Table 2.2  List of serum-containing cell culture tested in the study  
Short Name Culture Media Serum 
F12+10CS F12 (Ham's F12, Gibco®) 10% Calf Serum (Gibco®)  
DMEM+10FBS 
DMEM (Dulbecco's Modified 
Eagle Medium, Gibco®) 
10% Foetal Bovine Serum 
(Gibco®) 
MEM+20FBS 
MEM (Minimum Essential 
Medium, Gibco®) 
20% Foetal Bovine Serum 
(Gibco®) 
RPMI+10HS 
RPMI 1640 (Roswell Park Memorial 
Institute, Gibco®)  
10% Horse Serum (Gibco®) 
All other chemicals were purchased from Sigma Aldrich and used without further 
modifications. 
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2.2 Characterisation methods 
Stock suspensions of each NP sample were characterised using various techniques such 
as UV-Visible spectroscopy (UV-vis), Dynamic Light Scattering (DLS), Centrifugal liquid 
sedimentation method (CLS), Transmission Electron Microscopy (TEM).  
2.2.1 UV-Visible spectroscopy 
Metallic NPs with sizes smaller than the wavelength of light show strong dipolar 
excitations in the form of localized surface plasmon resonances. The resonance frequency 
of the oscillation, i.e. the plasmonic peak position of these materials depends on the 
dielectric properties of the metal and the surrounding medium and on the size and shape 
of the metallic particles. A shift in the λmax value of a metallic NP suspension to higher 
wavelengths might indicate the presence of an adsorbed layer on the particles and/or 
particle aggregation/agglomeration.19, 20 
UV-Vis spectra of stock solutions of gold and silver NPs were recorded with an Evolution 
300 UV-Vis Spectrophotometer (Thermo Scientific, USA) at room temperature. 
2.2.2 Dynamic light scattering 
DLS provides information about the hydrodynamic diameter distribution of the NPs in 
suspension. The resulting values are generally higher than particle sizes detected by 
electron microscopy because of the presence of hydration layer, protein corona or 
functionalisation and because results are generally biased in the presence of a small 
fraction of large particles or agglomerates*. This latter effect derives from the fact that 
(in a certain particle size range) the intensity of the scattered light is proportional to the 
sixth power of the radius of the nanoparticles. As a result, a small fraction of large 
particles may produce a strong optical signal which completely masks a large fraction of 
smaller particles. DLS does not distinguish between constituent particles and 
aggregates/agglomerates. It simply gives information about all diffusing ensembles, 
regardless of whether they are individual particles, agglomerates or aggregates. 
Consequently, DLS analysis of a polydisperse NP mixture will usually produce results 
which tend to reflect the size of the larger particles present in a solution even when these 
numerically constitute only a minor fraction of the total population.21, 22 
Particle size distribution (PSD) was determined by Dynamic Light Scattering (DLS) using 
a Zetasizer Nano-ZS instrument (Malvern Instruments Ltd, UK) with temperature control 
(25°C). Each sample was recorded in quadruplicate with an equilibration step of 120 sec. 
The instrument was set to automatic acquisition mode. Hydrodynamic diameters were 
calculated from the intensity-weighted particle size distributions derived from the 
measured correlogram using a NNLS fitting algorithm.  
2.2.3 Centrifugal liquid sedimentation 
Particle size measurement by Centrifugal Liquid Sedimentation (CLS) operates on the 
principle of separating particles by size and density using centrifugal sedimentation in a 
liquid medium. In the version of this technique more correctly known as “Line-start CLS” 
particles are injected into a liquid medium contained within an optically clear, rotating 
disc. Once the particles enter the rotating liquid media they sediment radially outwards 
at speed which is a function of their density and Stokes diameter.  At a certain point in 
time the particles pass through a narrow beam of light which shines through a region 
near the outside edge of the rotating disc.  As the particles pass through the detector 
beam the light is partially scattered and the transmitted light intensity decreases as 
function of concentration and size of the particles.  Simultaneously, the particle size is 
calculated from the sedimentation time. To establish the relationship between 
sedimentation time and particle size, each analysis is preceded by a calibration run 
performed using a narrowly distributed size standard. In order to stabilize sedimentation 
and avoid streaming, the spin fluid should have a small density gradient. During each 
measurement run the variation in light intensity is continuously recorded as a function of 
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sedimentation time and converted into an extinction-based size distribution that can be 
further transformed to a mass or number based distribution applying the Mie theory and 
using absorption, refractive index, and particle density as input parameters, and 
assuming the particles have a spherical shape. It should be noted that by using an 
operator input value for particles density, the Stokes diameters derived from CLS 
measurements might be biased if the real density of the sedimenting particles differs 
significantly from the expected (bulk) density of the material. This can typically occur 
with small NPs in the presence of an adsorbed layer (protein corona, functionalisation, 
etc.) with much lower density than the core material.2, 23 
In order to assess the particle size distributions of the nanoparticles, CLS characterisation 
was performed on the as synthesized nanoparticle dispersions. Measurements were run 
using a disc centrifuge (model DC24000UHR CPS Instruments), in an 8 wt% - 24 wt% 
sucrose density gradient at a disc rotational speed of 22000 rpm. Each sample injection 
of 100 µL was preceded by a calibration step performed using certified poly(vinyl 
chloride) (PVC) particle size standard with mean diameter of 239 nm (CPS Instruments). 
2.2.4 Transmission electron microscopy 
Transmission electron microscopy (TEM) allows direct imaging of the NPs. Combined with 
statistical analysis of the micrographs (with the help of image analysis software), TEM 
provides information on particle shape and number based size distributions. However, for 
good quality image analysis, the particles should be well dispersed and distributed on the 
grid. Unfortunately, simple TEM sample preparation methods (i.e. evaporation of the 
solvent) do not distinguish between agglomerates formed during the drying of the 
sample drop on the support (grid) and aggregates that were already present in the NP 
suspension.  
TEM analysis was done following the spotting of liquid particle dispersions on copper 
support grids. A drop of undiluted product (4 µL) was placed onto ultrathin Formvar-
coated 200-mesh copper grids (Tedpella Inc.) and left to dry in air at 4°C. NPs were 
visualized using TEM (JEOL 2100, Japan) at an accelerating voltage of 200 kV. Digital 
micrographs were analysed using the ImageJ software and a custom macro performing 
smoothing (3x3 or 5x5 median filter), manual global threshold and automatic particle 
analysis provided by ImageJ. For each sample, the size of at least 60 particles was 
measured to obtain an average diameter and the size distribution.  
2.2.5 Inductively Coupled Plasma Mass Spectrometry  
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) provides quantitative 
information about the elemental composition of the samples. ICP-MS measurements 
were performed using an Agilent 7700 ICP-MS instrument (Agilent Technologies Inc., 
USA) after acid digestion of the samples. 
2.3 Gold nanoparticles  
2.3.1 In house synthesis of gold nanoparticles 
The synthesis of the sodium citrate-stabilised 5 nm gold nanoparticles (Au NPs) was 
carried out by reduction of gold (III) chloride hydrate salt with the strong reducing agent 
NaBH4. Briefly, 96 mL of a sodium citrate solution (0.25 mM) in MilliQ water was stirred 
in an ice bath, to which 1 mL of aqueous solution of gold (III) chloride trihydrate 
(25 mM) was added. Then, 3 mL aqueous solution of sodium borohydrate (100 mM) was 
quickly added to the gold salt solution under vigorous stirring. The reduction of gold salt 
to gold nanoparticles by the sodium borohydrate produced a change in colour of the 
liquid from pale yellow to dark red. The suspension was then stirred in the ice bath for 
further 30 min and then left to warm to room temperature. The final pH value of the 
solution was 6.7 and the estimated nominal Au concentration (stoichiometry) was 
0.25 mM. 
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For the physico-chemical characterisation in different cell culture media (CCM), AuNPs 
5 nm were concentrated by centrifugal ultrafiltration using AMICON ULTRA-15 10 KDa 
filter tubes (Millipore, Milan, Italy). 10 mL AuNPs suspension was placed in each filter 
tube and centrifuged at 1500 rcf at room temperature for 20 min during which time the 
sample volume was reduced from 20 mL to 1.2 mL. The final concentration of the stock 
suspension measured by ICP-MS resulted to be 5.05 mM. The stock suspension was 
stored at 4°C in dark. 
The in-house synthesis of 30 nm AuNPs was carried out by a two-step seed growth 
method in which the reduction of gold (III) chloride hydrate salt in the presence of 
trisodium citrate dihydrate was used to selectively enlarge highly mono-dispersed 12 nm 
size gold seed particles. In the first step of the process, the 12 nm seed particles were 
obtained by a method adapted from that described by Turkevich et al.24 Briefly, the 
solution was heated up using a microwave apparatus (Discover S by CEM corporation) to 
ensure a highly reproducible rapid heating. In this method, 5 mL of tetrachloroauric acid 
trihydrate (HAuCl4 x 3H2O, 10 mM) was dissolved in 95 mL of water. The solution was 
rapidly heated up and held at 97°C for 5 min using a microwave power of 250 W under 
vigorous mechanical stirring; 2.5 mL of trisodium citrate dihydrate (100 mM) was added 
to the solution and kept at 97 °C for another 20 min. Afterwards, the solution was rapidly 
cooled down to 40°C and then to room temperature. The gold nanoparticles were 
produced by the reduction of the gold salt by sodium citrate that acted as both reducing 
agent and stabiliser. The final suspension contained 12 nm size gold nanoparticles 
(0.5 mM gold concentration) stabilized with 2.5 mM of sodium citrate at pH 6-7. 
In the second stage of the synthesis, 95 mL of MilliQ water was left to stir at 60°C for 
two hours. Sequentially, 2.8 mL of sodium citrate dehydrated (100 mM) and 0.420 mL of 
sodium hydroxide (200 mM) were added to the water and left to equilibrate for 30 min. 
Then 2.24 mL of tetrachloroauric acid trihydrate 10 mM (HAuCl4 x 3H2O) and 0.6 mL of 
the 12 nm gold nanoparticles with a gold concentration of 0.5 mM were added to the 
solution, under vigorous stirring. The solution was left to react for 48 h at 60°C. The final 
suspension contained 30 nm AuNPs stabilised with 2.8 mM of sodium citrate at pH 6.7. 
The calculated nominal gold concentration was 0.225 mM. 
For the physicochemical characterisation in different CCM, 30 nm AuNPs were 
concentrated by centrifugal ultrafiltration using the AMICON 10 KDa filter tubes 
(Millipore, Milan, Italy); 10 mL AuNP suspension was added on each filter and tubes were 
centrifuged for 20 min at 1500 rcf at room temperature. The final gold concentration was 
measured by UV-Vis and found to be 5.89 mM. This stock suspension was stored at 4°C 
away from light. 
2.3.2 TEM, UV-Visible, DLS and CLS characterisation of gold 
nanoparticles 
TEM micrographs of the 5 nm and 30 nm AuNPs are shown in Figure 2.1 together with 
results of the size distribution analysis. As a result of the sample preparation procedure 
(dried drop), particles appear as agglomerates in the TEM micrographs. Statistical size 
analysis after fitting the size distributions with a Gaussian distribution provided mean 
diameter values of 4.8 nm and 32 nm for the 5 and 30 nm nominal diameter particles, 
respectively. 
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Figure 2.1 TEM micrographs and number based particle size distributions with Gaussian fit of 
(A,B) and 5 nm AuNPs (C,D). 
 
Figure 2.2 UV-Vis spectra (A), CLS mass based size distributions (B) and DLS intensity based size 
distributions (C) of 5 nm (red) and 30 nm (green) gold nanoparticles. 
 
UV-Vis spectra (Figure 2.2 A) of the AuNPs show one well defined plasmonic peak (at 514 
nm and 527 nm), for each material at the expected wavelength corresponding to their 
diameters.25  
CLS measurements (Figure 2.2 B) suggested 4 nm and 27 nm size (mass based size 
distribution mode) for the two different AuNP suspensions. These values are very close to 
the TEM results (Table 2.3). The apparent shift to slightly lower diameters might be 
because of the effect of the hydration layer on the particle densities that causes longer 
sedimentation times than theoretically expected.23 
Hydrodynamic diameters (Figure 2.2 C) determined from the intensity based distribution 
means (9 and 39 nm) are higher than the TEM and CPS sizes due to the hydration layer 
covering the particles in aqueous suspension, or due to the width of the size distribution, 
or to a combination of both. All measurements suggest that the stock suspensions are 
monomodal, containing particles close to the expected nominal dimensions. 
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2.4 Silica nanoparticles 
2.4.1 In house synthesis of silica nanoparticles 
The 22 nm SiO2NPs were synthesised using a method adapted from Hartlen et al.
26. 
Briefly, cyclohexane (16.25 mL) was mixed with a solution of L-arginine (330 mg, 
1.9 mmol) in MilliQ water (250 mL). The mixture was heated to 50°C at a constant 
stirring rate of approximately 300 rpm before TEOS (20 mL) was slowly added and the 
reaction was kept under these conditions for 24 h. 
The concentration of 22 nm SiO2NPs in the stock suspension measured by gravimetric 
technique was 2.2 mg/mL. The stock suspension was stored at 4°C in dark. 
For the physicochemical characterisation in different CCM, 22 nm SiO2NPs were 
concentrated by centrifugal ultrafiltration using the AMICON 10 KDa filter tubes 
(Millipore, Milan, Italy); 10 mL SiO2NP suspension was measured in each filter tube and 
centrifuged for 20 min at 1500 rcf at room temperature. The final concentration was 
measured by gravimetric technique and found to be 8.8 mg/mL. The stock suspension 
was stored at 4°C away from light. 
2.4.2 TEM, DLS and CLS characterisation of silica NPs 
TEM micrographs of the 22 nm SiO2NPs (Figure 2.3 A) show particles with an equiaxial 
shape. Statistical size analysis after fitting the number based size distribution with a 
Gaussian fit provided a mean ECD (equivalent circle diameter) value of about 20 nm. 
 
 
Figure 2.3 TEM micrograph (A) and number based particle size distribution with Gaussian fit of (B) 
22 nm SiO2NPs. 
CLS measurement (Figure 2.4 A) suggested 23 nm size (modal value of the mass based 
size distribution) what is very close to the TEM diameter (Table 2.3).  
 
 
Figure 2.4 CLS mass based size distribution (A) and DLS intensity based size distribution (B) of 
the 22 nm silica nanoparticles. 
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Hydrodynamic diameter of the SiO2-NPs (Figure 2.4 B) determined from the intensity 
based distribution mean (31 nm) is higher than the TEM and CPS sizes - most probably 
both due to the hydration layer covering the particles in aqueous suspension and due to 
the bias caused by larger, more scattering particles. All measurements suggest that the 
stock suspension is monomodal, containing particles close to the expected nominal 
dimension. 
2.5 Silver nanoparticles 
Cit-AgNPs (30 nm) and PVP-AgNPs (30 nm) were purchased from NanoComposix. 
Cit-AgNPs were provided as a suspension containing 1.02 mg/mL silver (corresponding to 
a particle concentration of 5.3x1012 particles/mL) in an aqueous 2 mM citrate solution. 
They were reported to have a TEM diameter of 32.7 ± 4.8 nm, hydrodynamic diameter 
(DLS? Which DLS method?) of 35.6 nm, and a plasmonic peak at λmax= 403 nm. 
PVP-AgNPs were provided as a suspension containing 1.08 mg/mL silver (corresponding 
to a particle concentration of 5.6x1012 particles/mL) in MilliQ water. They were reported 
to have a TEM diameter of 32.7 ± 4.3 nm, hydrodynamic diameter of 51 nm, and a 
plasmonic peak at λmax= 403 nm. 
2.5.1 TEM, UV-Vis, DLS and CPS characterisation of silver nanoparticles 
In house TEM analysis of the Ag-NPs confirmed the spherical shape and the expected size 
of the particles. 
 
 
Figure 2.5 TEM micrographs of the 30 nm Cit-AgNPs (A) and 30 nm PVP-AgNPs (B). 
 
UV-Vis spectra of the Cit-AgNPs and PVP-AgNPs (Figure 2.6 A) were perfectly overlapping 
with negligible difference in the absorption peak maximum position (401 nm and 399 nm, 
respectively). The UV-Vis results also confirm, that the two silver particle samples have 
very similar sized metallic core. 
CLS measurements suggested apparently lower Stokes diameter for PVP-AgNPs than for 
Cit-AgNPs (Figure 2.6 B, Table 2.3). This apparent decrease in the particle size can be 
explained by the presence of the PVP coating on the particles, which leads to decreased 
total particle density and - as a consequence – longer sedimentation times. In standard 
computations using bulk silver density (10.49 g/mL) the longer sedimentation times will 
(incorrectly) result in lower calculated particle diameters.  
Considering the presence of the PVP coating, it is not surprising that DLS hydrodynamic 
diameter of the PVP-AgNPs was higher than the diameter of Cit-AgNPs (Figure 2.6 C) 
with higher polidispersity index (Table 2.3). However, all characterisation techniques 
suggest that the stock suspensions are monomodal, containing particles close to the 
declared nominal dimension. 
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Figure 2.6 UV-Vis spectra (A), CLS mass based size distributions (B) and DLS intensity based size 
distributions of 30 nm (C) Cit-AgNPs (red) and PVP-AgNps (green). 
2.6 Summary of morphology and sizing of all stock solutions 
TEM analysis was performed to determine the shape of the particles and to verify 
whether the PSD results from DLS and CLS measurements were representative of the 
single particles or agglomerates. The DLS and CLS measurements were conducted as 
described above on stock dispersions of the NPs (diluted in MilliQ water if necessary) and 
the results obtained are summarised in Table 2.3. The morphology of all NPs stock 
solutions obtained by transmission electron microscopy analysis is presented in Figure 
2.7. 
Table 2.3 Characterisation of size distribution (by TEM, DLS and CLS) of the stock suspensions 
NPs. TEM: number based mean diameter. DLS: Intensity based mean diameter. CLS: mass based 
size distribution mode.  
NPs 
Nominal size 
(nm) 
Size distribution 
 TEM 
(nm ± SD) 
DLS 
(nm /PdI1) 
CLS 
(nm/HHW2/PdI3) 
AuNPs 5 4.8 ± 1.0 9/0.21 4/2/1.6 
AuNPs 30 32 ± 11 39/0.25 27/7/1.2 
SiO2NPs 22 20 ± 7 31.4/0.06 23/11/1.1 
Cit-AgNPs 30 33 ± 5* 43.1/0.06 27/6/1.1 
PVP-AgNPs 30 33 ± 4* 70.5/0.17 20/6/1.1 
1DLS Polydispersity Index 
2Full Width at Half Maximum (FWHM) 
3CLS Polydispersivity Index (Dw/Dn) defined as distribution width of NPs’ mass based size distribution divided 
by distribution width of the NPs’ number based size distribution.  
* Data provided by supplier 
 
TEM images show that all the particles can be considered to be equiaxial and often 
approximately spherical and thus the generally used models are suitable in DLS and CLS 
based size estimations. A comparison of the TEM determined sizes with the 
hydrodynamic diameters (DLS size measures) show that hydrodynamic diameter values 
are generally higher than expected from TEM and CLS data.  
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Figure 2.7 Transmission Electron 
Microscopic analysis of 5 nm AuNPs 
(A); 30 nm AuNPs (B); 22 nm 
SiO2NPs (C); 30 nm Cit-AgNPs (D); 
30 nm PVP-AgNPs (E) (nominal 
diameters). 
A B 
C D 
E 
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3 Characterisation of nanoparticle stability in serum-
containing cell culture media 
In the previous sections the nanoparticle size distributions of the stock materials have 
been described as they are present in the simple dispersion or original synthesis media 
and without the presence of the proteins and salts which are vital components of the full 
cell culture media used in the validation test protocol. Under these conditions the 
particles are expected to be either fully dispersed (mainly single particles) as in the case 
of the selected materials or, in the case of suspensions derived from dried powders, to be 
a mixture of single particles and agglomerates/aggregates. The majority of particles in 
this study maintain their colloidal stability in their stock solution via electrostatic 
stabilisation which generally becomes less effective in the presence of dissolved ionic 
salts. At the salt concentration levels of cell culture media there is a high probability that 
a rapid and irreversible agglom of normally stable nanoparticles will occur. The presence 
of proteins may mitigate or exasperate the effect of salt depending on the nature of the 
particles and the proteins involved. Consequently, it is not generally possible to reliably 
predict how a certain type of particle will behave in any particular type of cell culture 
medium and thus it is generally advisable to determine this behaviour experimentally. In 
this study the colloidal stability of the test materials when exposed to different serum 
containing cell culture media has been qualitatively evaluated by using UV-Vis, DLS and 
CLS. A comparison was made between the samples immediately after dilution in water or 
serum-media mixture (time 0 hour) and after being held for 1, 4, 24 or 48 hours under 
standard cell culture conditions (5% CO2, 95% humidity and 37°C). The composition of 
each complete culture media is described in Table 2 (Chapter 2.1). Results of the NPs 
physical-chemical characterisation in different complete culture media are reported 
specifically for each NP. 
3.1 Description of characterisation methods 
3.1.1 UV-Visible spectroscopy 
UV-vis spectra were recorded with an EnSpire Multimode Plate Reader (Perkin Elmer) at 
37 °C. The NPs were diluted in water or complete culture medium (without phenol red) at 
37 °C at various final concentrations (5 nm AuNPs and 30 nm AuNPs : 300, 150, 75, 37.5 
and 18.75 µM, 30 nm Cit-AgNPs and 30 nm PVP-AgNPs: 20, 10, 5, 2.5, 1.25 µg/mL). The 
suspensions were homogenized for 20 seconds using vortex and the absorption spectra 
of NPs was recorded immediately after dilution (0 hour) and after incubated for 1, 4, 24 
or 48 hours under standard cell culture conditions (5% CO2, 95% humidity and 37°C). 
The experiment was repeated twice in triplicates. 
3.1.2 DLS measurements 
Particle size distribution (PSD) of NPs was determined by DLS using a Zetasizer Nano-ZS 
instrument (Malvern Instruments Ltd, UK) with temperature control (25°C). The NPs 
were diluted in water or complete culture medium at 37 °C at various final concentrations 
(30 nm AuNPs: 300 µM, 22 nm SiO2NPs: 1 and 0.1 mg/mL, 30 nm Cit-AgNPs and 30 nm 
PVP-AgNPs: 20 µg/mL). The suspensions were homogenized for 20 seconds using vortex 
and the particle size distribution of NPs was analyzed immediately after dilution (0 hour) 
and after incubation for 1, 4, 24 or 48 hours under standard cell culture conditions (5% 
CO2, 95% humidity and 37°C). Each sample was recorded in quadruplicate after a 
temperature equilibration step of 120 sec. The instrument was set to automatic 
acquisition mode. Hydrodynamic diameters were calculated from the DLS intensity-
weighted particle size distributions derived from NNLS fitting of the measured 
correlograms. 
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3.1.3 CLS measurements 
Particle size distributions of NPs were determined by CLS using a CPS instrument (model 
DC24000UHR, CPS Instruments). The NPs were diluted in water or complete culture 
medium at 37 °C at various final concentrations (5 nm AuNPs and 30 nm AuNPs: 300, 
100, 75 µM; 22 nm SiO2NPs: 1, 0.5 and 0.1 mg/mL; 30 nm Cit-AgNPs and 30 nm PVP-
AgNPs: 20 and 10 µg/mL). The suspensions were homogenized for 20 seconds using 
vortex and the particle size distribution of NPs was analysed immediately after dilution 
(0 hour) and after incubation for 1, 4, 24 or 48 hours under standard cell culture 
conditions (5% CO2, 95% humidity and 37°C). Measurements were performed in an 
8 wt% - 24 wt% sucrose density gradient at a disc speed of 22000 rpm. Each sample 
injection of 100 µL was preceded by a calibration step performed using certified 
poly(vinyl chloride) (PVC) particle size standard with a diameter of 239 nm (source?). 
3.2 Results 
3.2.1 Gold nanoparticles with diameter of 5 nm  
The position of the absorption band maximum measured by UV–vis spectrometry 
(513 nm) was in agreement with the value expected for 5 nm diameter AuNPs diluted in 
water. This value was constant after 48 hours of incubation at 37 °C in water. The 5 nm 
AuNPs incubated in various complete culture media had a shift in the absorption band 
maximum to higher wavelengths and these values showed an increase during 48 hours. 
These results are reported as absorption spectra and peak shifts in time in Figure 3.1.and 
numerically as positions of the maxima of the plasmon resonance peaks in Table 3.1 for 
the highest tested particle concentration. 
Table 3.1 Plasmon resonance peak position (nm) of 5 nm AuNPs in water and various culture 
media at 0, 1, 4, 24, 48 h time points after incubation at 300 µM concentration, at 37 °C. 
Time Water 
F12+ 
10%CS 
DMEM+ 
10%FBS 
MEM+ 
20%FBS 
RPMI+ 
10%HS 
0 h 513 516 522 516 513 
1 h 513 516 522 519 513 
4 h 513 516 522 522 513 
24h 513 522 534 522 534 
48h 513 522 534 534 534 
 
In case of such small NPs, the surface plasmon resonance (SPR) peak shifts of up to 
21 nm were unlikely to be attributable the protein corona formation only. Indeed 
according to Mie theory, the decay length of the plasmon peak shift is very short for 
small particles (around 1-2 nm) resulting in a very low sensitivity to the protein thickness 
increases beyond this value. Even if a clear peak widening is observed, the measured 
SPR peak shift may be due to some possible NP agglomeration (formation of dimers) in 
particular for DMEM and RPMI.  
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Figure 3.1 Absorption spectra of 5 nm AuNPs incubated in water or in various complete culture 
media at 300 µM concentration, at 37 °C for 0 (A), 1 (B), 4 (C), 24 (D) or 48 (E) hours; F) SPR 
peak position at various time points in the different culture media. 
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The moderate agglomeration of 5 nm AuNPs is confirmed by CLS showing somewhat 
widened mass based particle size distributions, with a tail at larger particle diameters 
compared to the particle size distribution in water. CLS results - at first sight - suggest a 
shift of particle size distribution modes to lower diameter values in serum containing 
culture media compared to water (Figure 3.2 A). This apparent decrease in the particle 
size can be explained by protein adsorption on the particles, which leads to decreased 
density and - as a consequence – longer sedimentation times. In standard computations 
using bulk gold densities, the longer sedimentation times will (incorrectly) result in lower 
calculated particle diameters. Considering also that the size of serum proteins is in a 
similar range as the size of these NPs (with diameter of the hydrated bovine serum 
albumin of about 6 nm) the change in particle size distributions and the shift of the mass 
based size distribution modes (Table 3.2.) in various culture media suggest the formation 
of only small agglomerates up to 24 hours at all tested particle concentrations. 
 
 
 
Figure 3.2 Mass based size distributions by CLS of 5 nm AuNPs incubated in water or in various 
culture media at 300 µM concentration, at 37 °C for 0 (A), 1 (B), or 24 (C) hours. 
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Table 3.2 Size distribution results by CLS for 5 nm AuNPs incubated in water or in various culture 
media at 37 °C for 0, 1 or 24 hours. 
 
1Half Height Width (HHW), 2CLS Polydispersity Index (Dw/Dn) defined as the mean of mass based size 
distribution divided by the mean of number based size distribution; nd: not determined. 
 
Particles with such small dimensions (<10 nm) cannot be properly characterised by DLS, 
because of the limitations of the method. The presence of serum proteins of similar size 
range in CCM further complicates the interpretation of DLS data. Therefore DLS results 
are not shown for 5 nm gold NPs in culture media. 
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3.2.2 Gold nanoparticles with diameter of 30 nm  
 
Figure 3.3 Absorption spectra of 30 nm AuNPs incubated in water or in various complete culture 
media at 300 µM concentration, at 37 °C for 0 (A), 1 (B), 4 (C), 24 (D) or 48 (E) hours. 
Position of the absorption band maximum measured by UV–vis spectrometry (525 nm) 
was in agreement with the value expected for 30 nm diameter AuNPs diluted in water. 
This value was constant for 48 hours of incubation at 37 °C in water.  
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Table 3.3 Plasmon resonance peak position (nm) of 30 nm AuNPs in water and various culture 
media at 0, 1, 4, 24, 48 h time points after incubation at 300 µM concentration, at 37 °C. 
Time Water 
F12+ 
10%CS 
DMEM+ 
10%FBS 
MEM+ 
20%FBS 
RPMI+ 
10%HS 
0 h 525 531 531 531 531 
1 h 525 531 531 531 531 
4 h 525 531 531 531 525 
24h 525 531 531 531 531 
48h 525 531 531 531 531 
 
 
 
Figure 3.4 Mass based size distributions by CLS of 30 nm AuNPs incubated at 300 µM in (A) water, 
(B) F12+10%CS, (C) DMEM+10%FBS, (D) MEM+20%FBS or (E) RPMI+10%HS at 37 °C for 0, 1, 
4, 24, 48 hours. 
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Incubation in various complete culture media resulted in a slight, immediate shift of the 
absorption band maximum to higher wavelengths (531 nm) with no further change up to 
48 hours. These results are reported as absorption spectra in Figure 3.3 and numerically 
as positions of the maxima of the plasmon resonance peaks in Table 3.3 for the highest 
tested particle concentration. 
The slight shift in the UV-Vis spectrum is most probably due to a moderate 
agglomeration of the particles in CCM. CLS measurements also confirm the formation of 
small agglomerates. As it is illustrated for the highest tested concentration in Figure 3.4, 
the particle size distribution of 30 nm Au NPS does not change in water for 48 hours. In 
serum containing media, the apparent particle diameter is decreased because of protein 
adsorption and corresponding density decrease. In parallel with this, size distributions 
are widened, and in case of MEM + 20% FBS and RPMI + 10% HS the size distribution 
becomes clearly multimodal, indicating the presence of dimers and small multimers. 
However, after the reaction with CCM components, size distributions do not change 
significantly with time up to 48 hours and do not depend on particle concentration in the 
investigated range (Table 3.4).  
 
Table 3.4 Size distribution by CLS of AuNPs 30 nm incubated in water or in various culture media  
for 0, 1, 4, 24 or 48 hours. 
 
1Half Height Width (HHW). 2CLS Polydispersivity Index (Dw/Dn) defined as size distribution of NPs’ weight 
divided by size distribution of the NPs’ number.  
 
During the DLS measurement series, these particles were sedimenting with the 
incubation time indicated by the dropping count rates (the amount of scattered light 
detected) shown in Figure 3.5 for the highest particle concentration. As the NPs 
sediment, the concentration of particles in the path of the laser light decreases, resulting 
in decreased count rates after 4 hours.  
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Figure 3.5 DLS count rates detected at various time points in the 300 µM suspension of 30 nm Au 
NPs in various culture media 
 
Immediately after the reaction with serum proteins, the intensity based size distribution 
of the NPs was shifted to higher diameters as shown in Figure 3.6 at 0 h and 1 h. (Data 
were not collected for the same batch after longer times because of the drop in the 
detected count rate, i.e. particle sedimentation). In complete culture media a small peak 
appears at about 10 nm diameter – corresponding to the serum proteins present in the 
suspension. The mean hydrodynamic diameter of the particles (second, main peak in the 
figure) is shifted from 49 to about 80 nm accompanied by the widening of the peak - 
indicating protein adsorption and the formation of small agglomerates in CCM. 
 
Figure 3.6 Intensity based size distributions (hydrodynamic diameter) of 30 nm Au NPs at (A) 0 h 
and (B) 1 h in water and in various culture media. 
 
Recalculation of the CLS diameters considering the real density of particles originated 
from the core-shell structure of the protein coated, hydrated particles results in very 
similar 47 and 67-81 nm diameter values for the particles in water and in the various 
culture media, respectively.2  
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3.2.3 Silica nanoparticles with diameter of 22 nm  
The density (~2.2 g/mL) of silica NPs synthesized by the method of Hartlen et al.26 
differs much less from the density of the hydrated protein corona than the density of bulk 
gold or silver. Consequently, the apparent shift of particle diameters to lower values 
described previously for 30 nm Au NPs is much less with silica and does not complicate 
data interpretation in CLS measurements. Silica NPs were stable in water for 48 hours at 
37 °C (Figure 3.7 A). They reacted promptly with components of F12 +10%FCS and 
RPMI + 10%HS, showing fast agglomeration (widening of the size distribution curves) 
and a shift of the size modes to values above 100 nm (Figure 3.7 B,E; Table 3.5). The 
agglomeration of the silica NPs is slower, but still obvious in DMEM and MEM containing 
10% FBS (Figure 3.7 C,D) suggesting that the serum component of the CCM plays a key 
role in the agglomeration process. As shown in Figure 3.8, neither serum free culture 
medium nor the 10% serum itself in water causes the size distribution shift.  
  
Figure 3.7 Size distribution by CLS of 22 nm SiO2 NPs incubated at 1 mg/mL concentration in (A) 
water, (B) F12+10%CS, (C) DMEM+10%FBS, (D) MEM+20%FBS or (E) RPMI+10%HS at 37 °C for 
0, 1, 4, 24, 48 hours. 
 
On the other hand, serum in culture media induces NP agglomeration depending on the 
composition (origin) of the serum. The process is also NP concentration dependent, with 
stronger agglomeration at higher particle concentrations (Table 3.5). 
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Figure 3.8 Size distribution by CLS of 22 nm SiO2 NPs incubated at 1 mg/mL concentration in 
water, water + 10% FBS, water + 10% CS, DMEM, DMEM+10%FBS, DMEM +10% CS, F12+ 
10%FBS and F12+10%CS at 37 °C for 24 hours. 
 
Table 3.5 Size distribution by CLS of 22 nm SiO2NPs incubated in water or in different culture 
media (F12+10%CS, DMEM+10%FBS, MEM+20%FBS or RPMI+10%HS ) at 0.1, 0.5 and 1 mg/mL 
concentration, at 37 °C for 0, 1, 4, 24 or 48 hours. 
 
1Half Height Width (HHW). 2CLS Polydispersity Index (Dw/Dn) defined as the mean of mass based size 
distribution divided by the mean of number based size distribution 
 
The CLS based results are also confirmed by DLS. The more pronounced agglomeration 
at higher concentration (Figure 3.9 B) results in particle sedimentation leading to 
decreased detected count rates. Particle sedimentation in F12 + 10% CS and RPMI + 
10%HS was visible to the naked eye. 
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Figure 3.9 DLS count rates detected at various time points in the (A) 0.1 mg/mL and (B) 1 mg/mL 
suspension of 22 nm silica NPs in various culture media 
 
The 22 nm SiO2NPs particles are stable in water for 48 h at 37°C at both investigated 
concentrations, and show prompt agglomeration in various serum containing culture 
media (Figure 3.10 A). The intensity based particle size distribution is shifted to higher 
diameters (MEM and DMEM in presence of FBS) or more peaks appear at higher sizes like 
in case of the RPMI + 10% HS and F12 +10%CS. At this point, most of the light arriving 
to the detector is scattered by the large agglomerates, therefore the calculated size 
distribution is dominated by these large particles and the Z-average value clearly 
indicates their presence (Table 3.6). At later time points (Figure 3.10 B) with the 
sedimentation of big particle agglomerates the serum proteins still in solution become the 
main light scattering component. As a result, zeta average values might decrease again 
(as in case of F12 +10%CS and RPMI+10%HS), but the PdI still indicates the 
polydisperse nature of the suspension (Table 3.6, last row). 
 
 
Figure 3.10 Intensity based size distributions (hydrodynamic diameter) of 22 nm silica NPs at 0 h 
(A) and 24 h (B) in water and in various culture media. 
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Table 3.6 Size distribution by DLS of 22 nm SiO2NPs incubated in water or in different culture 
media at 0.1 and 1 mg/mL concentrations,  at 37 °C for 0, 1, 4, 24 or 48 hours  
 
1DLS Polydispersity Index 
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3.2.4 Citrate stabilised silver nanoparticles with diameter of 30 nm  
 
Figure 3.11 Absorption spectra of 30 nm Cit-AgNPs incubated in water or in different complete 
culture media at 37 °C for 0 (A), 1 (B), 4 (C), 24 (D) or 48 (E) hours. 
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Position of the absorption band maximum measured by UV–vis spectrometry (402 nm) 
was in agreement with the value expected for 30 nm diameter AgNPs diluted in water. 
This value was constant for 48 hours of incubation at 37 °C in water. Incubation in 
various complete culture media resulted in a slight, immediate shift of the absorption 
band maximum to higher wavelengths (to 405-408 nm) with further slow increase up to 
48 hours. These results are reported as absorption spectra in Figure 3.11 and numerically 
as positions of the maxima of the plasmon resonance peaks in Table 3.7 for the higher 
tested (20 µg/mL) concentration. 
UV-Vis results suggest the formation of small particle agglomerates in serum containing 
media. 
 
Table 3.7. Maximum position of the plasmon resonance peak (nm) of 30 nm Cit-AgNPs 
in water and various culture media at 20 µg/mL concentration, 37 °C, after 0, 1, 4, 24, 
48 h incubation times. 
Time Water 
F12+ 
10%CS 
DMEM+ 
10%FBS 
MEM+ 
20%FBS 
RPMI+ 
10%HS 
0 h 402 408 408 408 405 
1 h 402 408 405 405 405 
4 h 399 408 408 405 405 
24h 399 411 411 408 408 
48h 399 411 414 408 411 
 
CLS measurements support this finding, showing widening of the size distribution peaks 
(Figure 3.12), increase of the polydispersity index (Table 3.8) and – similarly to Au NPs – 
a shift of the first size distribution mode to lower values because of the density decrease 
due to protein corona formation. In case of DMEM+10%FBS, MEM+20%FBS and 
RPMI+10%HS the peaks belonging to dimers and small multimers can be also well 
observed as shoulders of the main peak at higher diameters (Figure 3.12 C,D,E). 
Similarly to the 30 nm AuNPs, the citrate stabilised silver nanoparticles of similar size 
(and their small agglomerates) do not show sedimentation neither in water nor in 
complete CCM. DLS count rates remained stable (did not decrease) for 48 h as illustrated 
by Figure 3.13 for the higher tested concentration. A moderate increase of hydrodynamic 
diameter was detected by DLS even in water with time (Table 3.9) most probably 
indicating the formation of dimers. Intensity based size distribution means of the 
particles measured by DLS immediately increase in CCM from 39 nm to 85-170 nm 
depending on culture medium (Figure 3.14). Further strong agglomeration cannot be 
observed by DLS in any of the media at 20 µg/mL Cit-AgNP concentration. 
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Figure 3.12 Size distribution by CLS of 30 nm Cit-AgNPs incubated at 20 µg/mL concentration in 
(A) water or in (B) F12+10%CS, (C) DMEM+10%FBS, (D) MEM+20%FBS and (E) RPMI+10%HS at 
37 °C for 0, 1, 4, 24 and 48 hours. 
 
The calculated size distributions (Figure 3.13) are multimodal, with a small peak 
appearing at about 10 nm due to the presence of serum proteins in the CCM. Thus, Z-
average values reported in Table 3.9 have to be interpreted critically, as they reflect the 
average hydrodynamic diameter of a multimodal distribution. Nevertheless, the higher Z-
averages together with the increased polydispersivity index values confirm the formation 
of small agglomerates detected by CLS measurements. 
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Table 3.8 Size distribution by CLS of Cit-AgNPs 30 nm incubated with water or with different 
culture media. Cit-AgNPs 30 nm (10 and 20 µg/mL) were incubated with water, F12+10%CS, 
DMEM+10%FBS, MEM+20%FBS or RPMI+10%HS at 37 °C for 0, 1, 4, 24 or 48 hours and after the 
size distribution was evaluated by CLS. 
 
1Half Height Width (HHW). 
2CLS Polydispersity Index (Dw/Dn) defined as the mean of mass based size distribution divided by the mean of 
number based size distribution  
 
Figure 3.13 DLS count rates detected at various time points in the 20 µg/mL suspension of 30 nm 
Cit-AgNPs in various culture media 
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Figure 3.14 Intensity based size distributions (hydrodynamic diameter) of 30 nm Cit-AgNPs at (A) 
0 h and (B) 48 h in water and in various culture media. 
 
Table 3.9. Size distribution by DLS of Cit-AgNPs 30 nm incubated in water or in various culture 
media at 37 °C for 0, 1, 4, 24 or 48 hours. 
 
1DLS Polydispersity Index 
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3.2.5 PVP coated silver nanoparticles with diameter of 30 nm  
 
Figure 3.15 Absorption spectra of 30 nm PVP-AgNPs incubated in water or in different complete 
culture media at 37 °C for 0 (A), 1 (B), 4 (C), 24 (D) or 48 (E) hours.  
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UV-Vis absorption profile of the 30 nm PVP-AgNPs in water was found to be very similar 
to the Cit-AgNPs, having an absorption maximum at the expected wavelength. According 
to the plasmonic peak position (Figure 3.15. and Table 3.7.) they are stable in all tested 
CCM up to 24 h and show a slight shift of the peak position after 24 hours. 
Table 3.7. Maximum position of the plasmon resonance peak (nm) of 30 nm PVP-AgNPs in water 
and various culture media at 20 µg/mL concentration, 37 °C, after 0, 1, 4, 24, 48 h incubation 
times. 
Time Water 
F12+ 
10%CS 
DMEM+ 
10%FBS 
MEM+ 
20%FBS 
RPMI+ 
10%HS 
0 h 399 402 402 402 402 
1 h 399 402 402 402 402 
4 h 399 402 402 402 402 
24h 399 408 408 405 408 
48h 399 411 411 408 411 
 
Figure 3.16 Size distribution by CLS of 30 nm PVP-AgNPs incubated at 20 µg/mL concentration in 
(A) water or in (B) F12+10%CS, (C) DMEM+10%FBS, (D) MEM+20%FBS and (E) RPMI+10%HS at 
37 °C for 0, 1, 4, 24 and 48 hours. 
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PVP-AgNPs appear to be smaller than expected in CLS measurements (Figure 3.16 and 
Table 3.8) at a diameter of about 20 nm. As TEM images and UV-Vis spectra both 
confirm the nominal diameter, this observation can be explained by the presence of the 
hydrated polymer coating that can remarkably decrease the total density of the 30 nm 
silver particles. The Stokes diameter measured by CLS seems to be further decreasing 
with time in water (Figure 3.16 A) what can be most probably also attributed to the 
changes (swelling) of the PVP coating. The 30 nm PVP-AgNPs do not show notable 
agglomeration in any of the complete CCM, the detected diameter, peak with and 
polydispersity values remained stable for 48 hours in all tested media (Table 3.8). 
 
Table 3.8 Size distribution by CLS of PVP-AgNPs 30 nm incubated in water or in various culture 
media at 37 °C for 0, 1, 4, 24 or 48 hours. 
 
1Half Height Width (HHW). 
2CLS Polydispersity Index (Dw/Dn) defined as the mean of mass based size distribution divided by the mean of 
number based size distribution  
 
In accordance with the UV-Vis and CLS data, DLS measurements indicate that the 30 nm 
PVP-AgNPs are stable in culture media. No drop of the count rates was observed in any of 
the CCM for 48 hours. Hydrodynamic diameter (intensity based mean of the strongest 
peak) of the particles in water was about 80 nm and remained stable during the 
experiment. The quite high polydispersity index and a small peak appearing at about 10 
nm might be explained by the release of free PVP from the particles. The possible PVP 
release emphasizes the importance of testing also the effect of solvents and stabilisers in 
the next in vitro test development phase of the project. 
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Figure 3.17 DLS count rates detected at various time points in the 20 µg/mL suspension of 30 nm 
PVP-AgNPs in various culture media 
 
 
Figure 3.18 Intensity based size distributions (hydrodynamic diameter) of 30 nm PVP-AgNPs at 
(A) 0 h and (B) 48 h in water and in various culture media. 
 
In complete culture media also serum proteins contribute to the polydispersity of the 
samples. Therefore intensity based means of the main peaks (Figure 3.18) better 
represent the hydrodynamic diameter of these NPs than Z-average values (Table 3.9). In 
CCM the diameter of the particles immediately increases from 80 nm to 110-210 nm 
depending on the medium. The largest change can be observed for MEM and DMEM 
containing 20% and 10% FBS, respectively (Figure 3.18). After the initial interaction with 
the medium (absorption of serum proteins), particle diameters did not show notable size 
change during the experiment. The 30 nm PVP-AgNPs are stable in CCM also according to 
the DLS measurements. 
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Table 3.9 Size distribution by DLS of 30 nm PVP-AgNPs incubated in water or in different culture 
media at 20 µg/mL concentration, at 37 °C for 0, 1, 4, 24 or 48 hours. 
 
1DLS Polydispersity Index 
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4 Conclusions  
Physico-chemical characterisation of the synthesised and commercially sourced 
nanomaterials samples confirmed that the prepared stock suspensions contained 
equiaxial, mostly nearly-spherical nanoparticles with dimensions very close to the 
nominal particle size and with good monomodal size distribution. Experiments on the 
stock suspensions demonstrated that none of the single characterisation techniques is 
able to provide complete information on the samples. Therefore, several techniques were 
applied to observe the behaviour of the selected representative nanoparticles in complete 
CCM. 
Most of the tested samples exhibited some kind of agglomeration in serum containing 
CCM – dependent also on the composition of the medium and the origin of serum. Only 
the PVP functionalised AgNP sample showed the type of size distribution change in 
culture media that could be attributed solely to protein adsorption without notable 
agglomeration. SiO2 NPs were proven to be the most sensitive to interaction with serum 
containing CCM. The time and concentration dependent agglomeration of these particles 
was confirmed by both CLS and DLS measurements and in some cases the sedimentation 
of the large agglomerates generated was visible to the naked eye. In the case of 5 nm 
AuNPs, 30 nm AuNPs and 30 nm Cit-AgNPs the mild agglomeration led to the formation 
of dimers and small multimers and sedimentation of the 30 nm AuNPs was also 
observed. Table 4.1 summarises the information collected by the different methods about 
the behaviour of the samples (at the highest tested concentration) and the conclusions 
based on the comparative analysis of the data. 
Table 4.1 Observations collected about the behaviour of the tested nanoparticles in serum 
containing complete cell culture media 
Sample Methods Conclusion 
UV-Vis CLS DLS 
5 nm AuNPs small 
agglomerates 
small 
agglomerates 
N.A. mild agglomeration 
in CCM 
30 nm 
AuNPs 
small 
agglomerates 
small 
agglomerates 
prompt interaction 
with CCM 
sedimentation 
after 4 h 
interaction with all 
tested CCM, mild 
agglomeration and 
particle 
sedimentation 
22 nm 
SiO2NPs 
N.A. agglomeration 
affected 
mainly by 
serum 
component 
large 
agglomerates 
sedimentation 
fast agglomeration 
and sedimentation 
depending also on 
CCM composition  
30 nm 
Cit-AgNPs 
small 
agglomerates 
small 
agglomerates 
small 
agglomerates 
no sedimentation 
mild agglomeration 
generating small 
stable agglomerates 
30 nm  
PVP-AgNPs 
stable stable 
 
size shift 
depending on CCM 
composition 
stable in all CCM for 
48 h, possible PVP 
release 
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List of abbreviations and definitions 
 
Agglomerate* ISO/TS 80004-2:201 A collection of weakly bound particles or aggregates 
or mixtures of the two where the resulting external surface area is similar 
to the sum of the surface areas of the individual components 
Aggregate** ISO/TS 80004-2:201 A particle comprising strongly bonded or fused 
particles where the resulting external surface area may be significantly 
smaller than the sum of calculated surface areas of the individual 
components  
CCM Cell culture media 
Cit Citrate stabilised 
CS Calf Serum 
CLS Centrifugal Liquid Sedimentation 
DLS Dynamic Light Scattering 
FBS Foetal Bovine Serum 
HS Horse Serum 
ICP-MS Inductively Coupled Plasma mass Spectrometry  
JRC  Joint Research Centre 
NM Nanomaterial 
NMs Nanomaterials 
NP Nanoparticle 
OECD Organisation for Economic Co-operation and Development 
PVP Polyvinylpyrrolidone 
TEM Transmission Electron Microscope 
UV-Vis UV-Visible 
WPMN Working Party of Manufactured Nanomaterials 
Z-average Zeta-average 
 
(*/**) Use of terms agglomerate and aggregate   
In this work no specific studies were conducted to distinguish between agglomerates and 
aggregates as defined above. In the absence of this information the term agglomerate 
will generally be used to refer to all collections of bound single particles, aggregates or 
mixtures of both irrespective of the effective bonding strength.  
 
 
 42 
List of figures 
Figure 2.1 TEM micrographs and number based particle size distributions with Gaussian 
fit of (A,B) and 5 nm AuNPs (C,D). .........................................................................10 
Figure 2.2 UV-Vis spectra (A), CLS mass based size distributions (B) and DLS intensity 
based size distributions (C) of 5 nm (red) and 30 nm (green) gold nanoparticles. .........10 
Figure 2.3 TEM micrograph (A) and number based particle size distribution with 
Gaussian fit of (B) 22 nm SiO2NPs. .........................................................................11 
Figure 2.4 CLS mass based size distribution (A) and DLS intensity based size distribution 
(B) of the 22 nm silica nanoparticles. ......................................................................11 
Figure 2.5 TEM micrographs of the 30 nm Cit-AgNPs (A) and 30 nm PVP-AgNPs (B). ...12 
Figure 2.6 UV-Vis spectra (A), CLS mass based size distributions (B) and DLS intensity 
based size distributions of 30 nm (C) Cit-AgNPs (red) and PVP-AgNps (green). ............13 
Figure 2.7 Transmission Electron Microscopic analysis of 5 nm AuNPs (A); 30 nm AuNPs 
(B); 22 nm SiO2NPs (C); 30 nm Cit-AgNPs (D); 30 nm PVP-AgNPs (E) (nominal 
diameters). ..........................................................................................................14 
Figure 3.1 Absorption spectra of 5 nm AuNPs incubated in water or in various complete 
culture media at 300 µM concentration, at 37 °C for 0 (A), 1 (B), 4 (C), 24 (D) or 48 (E) 
hours; F) SPR peak position at various time points in the different culture media. ........17 
Figure 3.2 Mass based size distributions by CLS of 5 nm AuNPs incubated in water or in 
various culture media at 300 µM concentration, at 37 °C for 0 (A), 1 (B), or 24 (C) hours.
 ..........................................................................................................................18 
Figure 3.3 Absorption spectra of 30 nm AuNPs incubated in water or in various complete 
culture media at 300 µM concentration, at 37 °C for 0 (A), 1 (B), 4 (C), 24 (D) or 48 (E) 
hours. .................................................................................................................20 
Figure 3.4 Mass based size distributions by CLS of 30 nm AuNPs incubated at 300 µM in 
(A) water, (B) F12+10%CS, (C) DMEM+10%FBS, (D) MEM+20%FBS or (E) 
RPMI+10%HS at 37 °C for 0, 1, 4, 24, 48 hours. .....................................................21 
Figure 3.5 DLS count rates detected at various time points in the 300 µM suspension of 
30 nm Au NPs in various culture media ...................................................................23 
Figure 3.6 Intensity based size distributions (hydrodynamic diameter) of 30 nm Au NPs 
at (A) 0 h and (B) 1 h in water and in various culture media. .....................................23 
Figure 3.7 Size distribution by CLS of 22 nm SiO2 NPs incubated at 1 mg/mL 
concentration in (A) water, (B) F12+10%CS, (C) DMEM+10%FBS, (D) MEM+20%FBS or 
(E) RPMI+10%HS at 37 °C for 0, 1, 4, 24, 48 hours. ................................................24 
Figure 3.8 Size distribution by CLS of 22 nm SiO2 NPs incubated at 1 mg/mL 
concentration in water, water + 10% FBS, water + 10% CS, DMEM, DMEM+10%FBS, 
DMEM +10% CS, F12+ 10%FBS and F12+10%CS at 37 °C for 24 hours. ....................25 
Figure 3.9 DLS count rates detected at various time points in the (A) 0.1 mg/mL and 
(B) 1 mg/mL suspension of 22 nm silica NPs in various culture media .........................26 
Figure 3.10 Intensity based size distributions (hydrodynamic diameter) of 22 nm silica 
NPs at 0 h (A) and 24 h (B) in water and in various culture media. .............................26 
Figure 3.11 Absorption spectra of 30 nm Cit-AgNPs incubated in water or in different 
complete culture media at 37 °C for 0 (A), 1 (B), 4 (C), 24 (D) or 48 (E) hours. ..........28 
Figure 3.12 Size distribution by CLS of 30 nm Cit-AgNPs incubated at 20 µg/mL 
concentration in (A) water or in (B) F12+10%CS, (C) DMEM+10%FBS, (D) 
MEM+20%FBS and (E) RPMI+10%HS at 37 °C for 0, 1, 4, 24 and 48 hours. ...............30 
 43 
Figure 3.13 DLS count rates detected at various time points in the 20 µg/mL suspension 
of 30 nm Cit-AgNPs in various culture media ............................................................31 
Figure 3.14 Intensity based size distributions (hydrodynamic diameter) of 30 nm Cit-
AgNPs at (A) 0 h and (B) 48 h in water and in various culture media. .........................32 
Figure 3.15 Absorption spectra of 30 nm PVP-AgNPs incubated in water or in different 
complete culture media at 37 °C for 0 (A), 1 (B), 4 (C), 24 (D) or 48 (E) hours. ..........33 
Figure 3.16 Size distribution by CLS of 30 nm PVP-AgNPs incubated at 20 µg/mL 
concentration in (A) water or in (B) F12+10%CS, (C) DMEM+10%FBS, (D) 
MEM+20%FBS and (E) RPMI+10%HS at 37 °C for 0, 1, 4, 24 and 48 hours. ...............34 
Figure 3.17 DLS count rates detected at various time points in the 20 µg/mL suspension 
of 30 nm PVP-AgNPs in various culture media ..........................................................36 
Figure 3.18 Intensity based size distributions (hydrodynamic diameter) of 30 nm PVP-
AgNPs at (A) 0 h and (B) 48 h in water and in various culture media. .........................36 
 
 44 
List of tables 
Table 2.1 List of nanomaterials tested in the study ................................................... 6 
Table 2.2 List of serum-containing cell culture tested in the study .............................. 6 
Table 2.3 Characterisation of size distribution (by TEM, DLS and CLS) of the stock 
suspensions NPs. TEM: number based mean diameter. DLS: Intensity based mean 
diameter. CLS: mass based size distribution mode....................................................13 
Table 3.1 Plasmon resonance peak position (nm) of 5 nm AuNPs in water and various 
culture media at 0, 1, 4, 24, 48 h time points after incubation at 300 µM concentration, 
at 37 °C. .............................................................................................................16 
Table 3.2 Size distribution results by CLS for 5 nm AuNPs incubated in water or in 
various culture media at 37 °C for 0, 1 or 24 hours. .................................................19 
Table 3.3 Plasmon resonance peak position (nm) of 30 nm AuNPs in water and various 
culture media at 0, 1, 4, 24, 48 h time points after incubation at 300 µM concentration, 
at 37 °C. .............................................................................................................21 
Table 3.4 Size distribution by CLS of AuNPs 30 nm incubated in water or in various 
culture media  for 0, 1, 4, 24 or 48 hours. ...............................................................22 
Table 3.5 Size distribution by CLS of 22 nm SiO2NPs incubated in water or in different 
culture media (F12+10%CS, DMEM+10%FBS, MEM+20%FBS or RPMI+10%HS ) at 0.1, 
0.5 and 1 mg/mL concentration, at 37 °C for 0, 1, 4, 24 or 48 hours. .........................25 
Table 3.6 Size distribution by DLS of 22 nm SiO2NPs incubated in water or in different 
culture media at 0.1 and 1 mg/mL concentrations,  at 37 °C for 0, 1, 4, 24 or 48 hours 27 
Table 3.8 Size distribution by CLS of Cit-AgNPs 30 nm incubated with water or with 
different culture media. Cit-AgNPs 30 nm (10 and 20 µg/mL) were incubated with water, 
F12+10%CS, DMEM+10%FBS, MEM+20%FBS or RPMI+10%HS at 37 °C for 0, 1, 4, 24 
or 48 hours and after the size distribution was evaluated by CLS. ...............................31 
Table 3.9. Size distribution by DLS of Cit-AgNPs 30 nm incubated in water or in various 
culture media at 37 °C for 0, 1, 4, 24 or 48 hours. ...................................................32 
Table 3.7. Maximum position of the plasmon resonance peak (nm) of 30 nm PVP-AgNPs 
in water and various culture media at 20 µg/mL concentration, 37 °C, after 0, 1, 4, 24, 
48 h incubation times............................................................................................34 
Table 3.8 Size distribution by CLS of PVP-AgNPs 30 nm incubated in water or in various 
culture media at 37 °C for 0, 1, 4, 24 or 48 hours. ...................................................35 
Table 3.9 Size distribution by DLS of 30 nm PVP-AgNPs incubated in water or in different 
culture media at 20 µg/mL concentration, at 37 °C for 0, 1, 4, 24 or 48 hours. ............37 
Table 4.1 Observations collected about the behaviour of the tested nanoparticles in 
serum containing complete cell culture media ..........................................................38 
 
 
  
 
  
GETTING IN TOUCH WITH THE EU 
In person 
All over the European Union there are hundreds of Europe Direct information centres. You can find the 
address of the centre nearest you at: http://europea.eu/contact 
On the phone or by email 
Europe Direct is a service that answers your questions about the European Union. You can contact this 
service: 
- by freephone: 00 800 6 7 8 9 10 11 (certain operators may charge for these calls), 
- at the following standard number: +32 22999696, or 
- by electronic mail via: http://europa.eu/contact 
FINDING INFORMATION ABOUT THE EU 
Online 
Information about the European Union in all the official languages of the EU is available on the Europa 
website at: http://europa.eu 
EU publications 
You can download or order free and priced EU publications from EU Bookshop at: 
http://bookshop.europa.eu. Multiple copies of free publications may be obtained by contacting Europe 
Direct or your local information centre (see http://europa.eu/contact). 
  
 
K
J-N
A
-2
9
0
5
4
-E
N
-N
 
doi:10.2760/818663 
ISBN 978-92-79-77705-9 
